[Hanyu Pharmaceutical: signing an order for API equivalent to RMB 50 million yuan] Hanyu Pharmaceutical said on the interactive platform that it had recently signed a single commercial export order for API equivalent to RMB 50 million. Hanyu Pharmaceutical's API R & D and production base has passed overseas on-site verification, has perfect product development, production and export qualifications, and has bargaining power in the international market. The global API business has achieved a rapid year-on-year growth of 59.36% / 112.33% in the past three years. The company's API export business has entered the harvest period, and its market share will further increase in the future.